Hologic, Inc.
Health
Performance
1.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

Hologic, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

07.06.2026
Losing steam. Solid pieces remain, but cracks are showing.
28.05.2026
Rock solid. Minimal risk, max control.
28.04.2026
Slight bounce. Could be noise – or a comeback brewing.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.
HOLX
Hologic, Inc.
76.01
+0.00%
1.8
Sell
Buy
Hologic, Inc.

Hologic, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Hologic, Inc. do? Business model and key facts

Get the full picture of Hologic, Inc.: what it builds, where it operates, and how it makes money.

Hologic, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 7063

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

shop
Company facts
Paul Malenchini
CEO
7063
Employees worldwide
shop
Performance
37.13%
Last 12 months
15.82%
Last 5 years
shop
Growth
$4.10B
Revenue year
$565.70M
Net income
shop
Valuation
$16.97B
Market Cap
26.88
Price/Earnings Ratio

Stocks related to Hologic, Inc.

Selected based on industry alignment and relative market positioning.

WST
West Pharmaceutical Services, Inc.
359.24
+1.96%
4.6
Sell
Buy
West Pharmaceutical Services, Inc.
BDX
Low-poly 3D Becton Dickinson (BDX) stock icon with a stylized syringe, symbolizing healthcare and medical devices.
153.84
-0.41%
3.0
Sell
Buy
Becton, Dickinson and Company
COO
The Cooper Companies, Inc.
71.01
-0.81%
3.9
Sell
Buy
The Cooper Companies, Inc.
BAX
Baxter International Inc.
22.21
+0.63%
5.8
Sell
Buy
Baxter International Inc.
ATR
AptarGroup, Inc.
128.91
-0.77%
4.9
Sell
Buy
AptarGroup, Inc.

Events and news impacting Hologic, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Hologic, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.